Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

A twice-a-year shot to prevent HIV being dubbed a "wonder drug" by some could be coming to Canada as soon as next year, ...

The heads of national HIV organizations have stepped up their advocacy, asking Congress to oppose cuts in President Donald ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

In a song out during Pride month and ahead of HIV testing day on June 27, a Nashville country singer discusses his own ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.